Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Micrus Endovascular and Genesis Medical Interventional Sign License, Development and Commercialization Agreement
February 2nd, 2008
Micrus Endovascular Corporation (Nasdaq:MEND) and privately held Genesis Medical Interventional, Inc. announced that they have entered into an agreement granting Micrus the rights to Genesis' F.A.S.T.(TM) Funnel Catheter(TM) and clot retrieval system for the treatment of ischemic stroke. The transaction includes an initial upfront payment, future development milestone payments and an undisclosed royalty on potential future products sales. "Gaining access to this novel occlusion technology clearly expands our product offering and reach into the ischemic stroke market. Additionally, because of the F.A.S.T. Funnel Catheter's proprietary design, we believe that it will also...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2008-02-02)
|
